Penumbra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
CEOAdam Elsesser
CEOAdam Elsesser
Employees4,500
Employees4,500
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded2004
Founded2004
Employees4,500
Employees4,500
PEN Key Statistics
Market cap9.90B
Market cap9.90B
Price-Earnings ratio66.98
Price-Earnings ratio66.98
Dividend yield—
Dividend yield—
Average volume314.48K
Average volume314.48K
High today$254.41
High today$254.41
Low today$250.30
Low today$250.30
Open price$253.10
Open price$253.10
Volume170.78K
Volume170.78K
52 Week high$310.00
52 Week high$310.00
52 Week low$198.68
52 Week low$198.68
PEN News
Simply Wall St 3d
Penumbra: Evaluating Valuation After Needham Upgrade and New Growth CatalystsPenumbra (PEN) has caught investors' attention after Needham upgraded the stock. The upgrade was based on upcoming product launches, strong trial results, and a...
Simply Wall St 5d
How Needham’s Upgrade and Thunderbolt Launch Could Impact Penumbra InvestorsShares of medical device company Penumbra recently advanced after Needham upgraded its rating, citing expectations for stronger growth driven by upcoming produc...
Analyst ratings
81%
of 21 ratingsBuy
81%
Hold
14.3%
Sell
4.8%
People also own
Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.